An attempt to change the grandfather date in the FDA’s deeming regulations will not be taken up in the current lame-duck session of the U.S. Congress, a key law-maker in that effort said Thursday.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.